The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 23,400 shares, a growth of 216.2% from the December 31st total of 7,400 shares. Based on an average trading volume of 28,300 shares, the short-interest ratio is currently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock opened at $18.96 on Friday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 1-year low of $17.48 and a 1-year high of $20.85. The stock’s 50 day moving average price is $18.55 and its 200 day moving average price is $19.15.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Saturday, February 15th. Stockholders of record on Saturday, February 1st will be paid a dividend of $0.2891 per share. This represents a $1.16 annualized dividend and a dividend yield of 6.10%. The ex-dividend date of this dividend is Friday, January 31st. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.